SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 105.39-2.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Troll_29 who wrote (983)4/17/1999 12:42:00 AM
From: scaram(o)uche  Read Replies (1) of 3202
 
>> Where is the threat that scares the big pharmas to the point where they contemplate "a cooperative effort." <<

3% royalties, downstream, for access to data that they hope to make generic.

This wouldn't happen, but picture a period of 10 years where INCY was the exclusive provider of such info. If pharma is correct in the assumption that genomic databases will lead to new drug targets and or biologicals, then INCY could shut down in 10 years, become a virtual company with a skeleton staff, and yet be one of the world's largest pharmas.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News